A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML

NCT05341050 · clinicaltrials.gov ↗
RECRUITING
Status
260
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

xuna